These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 33187981)
21. Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy. Böhm J; Vasli N; Maurer M; Cowling BS; Shelton GD; Kress W; Toussaint A; Prokic I; Schara U; Anderson TJ; Weis J; Tiret L; Laporte J PLoS Genet; 2013 Jun; 9(6):e1003430. PubMed ID: 23754947 [TBL] [Abstract][Full Text] [Related]
22. Amphiphysin-2 (BIN1) functions and defects in cardiac and skeletal muscle. Giraud Q; Laporte J Trends Mol Med; 2024 Jun; 30(6):579-591. PubMed ID: 38514365 [TBL] [Abstract][Full Text] [Related]
23. Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation. Chin YH; Lee A; Kan HW; Laiman J; Chuang MC; Hsieh ST; Liu YW Hum Mol Genet; 2015 Oct; 24(19):5542-54. PubMed ID: 26199319 [TBL] [Abstract][Full Text] [Related]
24. Centronuclear myopathies: a widening concept. Romero NB Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480 [TBL] [Abstract][Full Text] [Related]
29. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness. Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436 [TBL] [Abstract][Full Text] [Related]
30. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model. Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559 [TBL] [Abstract][Full Text] [Related]
31. Cells Control BIN1-Mediated Membrane Tubulation by Altering the Membrane Charge. Gowrisankaran S; Wang Z; Morgan DG; Milosevic I; Mim C J Mol Biol; 2020 Feb; 432(4):1235-1250. PubMed ID: 31857086 [TBL] [Abstract][Full Text] [Related]
32. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy. Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900 [TBL] [Abstract][Full Text] [Related]
33. Novel Dominant Mutation in BIN1 Gene Causing Mild Centronuclear Myopathy Revealed by Myalgias and CK Elevation. Garibaldi M; Böhm J; Fattori F; Koch C; Surace C; Ottaviani P; Laschena F; Laporte J; Bertini E; Antonini G; Romero NB J Neuromuscul Dis; 2016 Mar; 3(1):111-114. PubMed ID: 27854204 [TBL] [Abstract][Full Text] [Related]
34. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances. Gómez-Oca R; Cowling BS; Laporte J Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808 [TBL] [Abstract][Full Text] [Related]
35. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves. Tinelli E; Pereira JA; Suter U Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975 [TBL] [Abstract][Full Text] [Related]